Skip to content
← Back to this collection

PUBLICATIONS · 18664623

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2008 Oct 15
First author
Sanz MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Sanz MA
      type
      Author
    2. name
      Montesinos P
      type
      Author
    3. name
      Vellenga E
      type
      Author
    4. name
      Rayón C
      type
      Author
    5. name
      de la Serna J
      type
      Author
    6. name
      Parody R
      type
      Author
    7. name
      Bergua JM
      type
      Author
    8. name
      León A
      type
      Author
    9. name
      Negri S
      type
      Author
    10. name
      González M
      type
      Author
    11. name
      Rivas C
      type
      Author
    12. name
      Esteve J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Sanz MA
      type
      Author
    2. name
      Montesinos P
      type
      Author
    3. name
      Vellenga E
      type
      Author
    4. name
      Rayón C
      type
      Author
    5. name
      de la Serna J
      type
      Author
    6. name
      Parody R
      type
      Author
    7. name
      Bergua JM
      type
      Author
    8. name
      León A
      type
      Author
    9. name
      Negri S
      type
      Author
    10. name
      González M
      type
      Author
    11. name
      Rivas C
      type
      Author
    12. name
      Esteve J
      type
      Author
    bibliography ids
    1. nci-bib-f2501158c812f8e3abb7a49f
    book metadata
    content sha256
    f7c66d55a5e765a64d4326ce72790d654a65d9857da19c0d041935a09a58d237
    document type
    citation
    dois
    1. 10.1182/blood-2008-05-159632
    electronic publication date
    display
    2008 Jul 29
    precision
    day
    year
    2008
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:18664623
    immutable id
    pubmed:18664623@f7c66d55a5e765a64d4326ce72790d654a65d9857da19c0d041935a09a58d237
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    8
    name
    Blood
    nlm unique id
    7603509
    pages
    3130-4
    volume
    112
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      18664623
      provenance
      batch id
      6281e3e555c9a831cffc
      provider
      NCBI PubMed ESummary
      record sha256
      3c7e480db0801f4db5e15593720b5839127bbc57be32176755528a3427f41ac4
      response sha256
      0bb4ba3914464c472d4206a84abe8224c9e76dc003114204593648964c5bf66c
      retrieved at
      2026-09-09T23:46:21.772457+00:00
      publication date
      display
      2008 Oct 15
      precision
      day
      year
      2008
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/18664623/
      title
      Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.

      Preserved source evidence · Not medical advice